Welcome to CDC Stacks | NIOSH skin notation (SK) profile; ethylene glycol dinitrate (EGDN) [CAS No. 628-96-6] - 5983 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
NIOSH skin notation (SK) profile; ethylene glycol dinitrate (EGDN) [CAS No. 628-96-6]
  • Published Date:
    April 2011
Filetype[PDF - 9.95 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
NIOSH skin notation (SK) profile; ethylene glycol dinitrate (EGDN) [CAS No. 628-96-6]
Details:
  • Corporate Authors:
    National Institute for Occupational Safety and Health, Education and Information Division.
  • Series:
    DHHS publication ; no. (NIOSH) 2011-143
  • Description:
    Foreword -- Abbreviations -- Glossary -- Acknowledgments -- 1. Introduction -- 1.1. General Substance Information -- 1.2. Purpose -- 1.3. Overview of SK Assignment for EGDN -- 2. Systemic Toxicity from Skin Exposure (SK: SYS) -- 3. Direct Effects on Skin (SK: DIR) -- 4 Immune-mediated Responses (SK: SEN) -- 5. Summary -- References -- Appendix: Calculation of the SI Ratio for EGDN

    "This Skin Notation Profile presents (1) a brief summary of technical data associated with skin contact with ethylene glycol dinitrate (EGDN) and (2) the rationale behind the hazard-specific skin notation (SK) assignment for EGDN. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009]. The summarized information and health hazard assessment are limited to an evaluation of the potential health effects of dermal exposure to EGDN. A literature search was conducted through July 2010 to identify information on EGDN, including but not limited to data relating to its toxicokinetics, acute toxicity, repeated-dose systemic toxicity, carcinogenicity, biological system/function-specific effects (including reproductive and developmental effects and immunotoxicity), irritation, and sensitization. Information was considered from studies of humans, animals, or appropriate modeling systems that are relevant to assessing the effects of dermal exposure to EGDN. EGDN is potentially capable of causing systemic toxic effects following skin contact. A critical review of available data has resulted in the following SK assignment for EGDN: SK: SYS. Table 1 provides an overview of the critical effects and data used to develop the SK assignment for EGDN." - NIOSHTIC-2

  • Supporting Files:
    No Additional Files